Safety-First, Severity-Adapted Enhanced Recovery After Surgery for Patients with Neurodegenerative Disorders: A Narrative Review and Proposed Framework.
4 affiliations
- 1Department of Anesthesiology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, 321000, People's Republic of China.
- 2Department of Anesthesia and Pain Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.
- 3Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.
- 4Department of Biology, Duke University, Durham, NC, 27708, USA.
Abstract
Enhanced Recovery After Surgery (ERAS) pathways have been shown to improve perioperative outcomes in broad surgical populations. However, their safety, feasibility, and optimal adaptation remain uncertain in patients with neurodegenerative disorders (NDDs), particularly those with dementia and Parkinson's disease. These patients often present with cognitive impairment and disability, which pose major perioperative care challenges. Our narrative review elucidates the pathophysiological traits, perioperative risks, and medication-related complications of patients with NDDs. We determine potential risks related to standard ERAS components, outline important drug-drug interactions between frequently prescribed NDD medications and anesthetic agents. We also offer useful suggestions for preoperative evaluation, intraoperative management, postoperative recovery, and post-discharge rehabilitation. We then present a three‑tier severity‑adapted ERAS framework, in which patients are stratified into mild, moderate, or severe groups based on the Hoehn and Yahr staging scale for Parkinson's disease and the Clinical Dementia Rating for dementia. This framework provides recommendations for the retention, modification, or restriction of ERAS components. We postulate that in this vulnerable population, the stratified decision-making pathways may help preserve the benefits of enhanced recovery while reducing avoidable iatrogenic harm and improving clinical feasibility. This, however, represents a conceptual framework requiring prospective validation.
Related
- Post-traumatic cognitive decline and neurodegenerative disease: a narrative review and proposed framework for etiologic assessment.
- Occurrence and Severity of Mental Health Disorders Among Patients Treated for Malignant Neoplasms: A Narrative Review with Preliminary Quantitative Synthesis.
- Harnessing Artificial Intelligence and ChatGPT in Early Detection of Neurodegenerative Disorders: A Transformative Opportunity for Neurology
- Targeting Sirtuins in Neurodegenerative and Psychiatric Disorders: From Molecular Mechanisms to Pharmacological Modulation
- The Functional Connectivity of Hallucinations in Psychiatric Disorders and Neurodegenerative Disorders: A Systematic Review
BibTeX
@article{lv2026safetyfirst,
title = {{Safety-First, Severity-Adapted Enhanced Recovery After Surgery for Patients with Neurodegenerative Disorders: A Narrative Review and Proposed Framework.}},
author = {Huayan Lv and Tong Wang and Chenyan Sun and Yang Hu and Su Min},
journal = {Clinical interventions in aging},
year = {2026},
month = nov,
doi = {10.2147/cia.s636393},
url = {https://europepmc.org/article/MED/42997323},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Safety-First, Severity-Adapted Enhanced Recovery After Surgery for Patients with Neurodegenerative Disorders: A Narrative Review and Proposed Framework.
AU - Huayan Lv
AU - Tong Wang
AU - Chenyan Sun
AU - Yang Hu
AU - Su Min
PY - 2026
DA - 2026/11/02
JO - Clinical interventions in aging
DO - 10.2147/cia.s636393
UR - https://europepmc.org/article/MED/42997323
AB - Enhanced Recovery After Surgery (ERAS) pathways have been shown to improve perioperative outcomes in broad surgical populations. However, their safety, feasibility, and optimal adaptation remain uncertain in patients with neurodegenerative disorders (NDDs), particularly those with dementia and Parkinson's disease. These patients often present with cognitive impairment and disability, which pose major perioperative care challenges. Our narrative review elucidates the pathophysiological traits, perioperative risks, and medication-related complications of patients with NDDs. We determine potential risks related to standard ERAS components, outline important drug-drug interactions between frequently prescribed NDD medications and anesthetic agents. We also offer useful suggestions for preoperative evaluation, intraoperative management, postoperative recovery, and post-discharge rehabilitation. We then present a three‑tier severity‑adapted ERAS framework, in which patients are stratified into mild, moderate, or severe groups based on the Hoehn and Yahr staging scale for Parkinson's disease and the Clinical Dementia Rating for dementia. This framework provides recommendations for the retention, modification, or restriction of ERAS components. We postulate that in this vulnerable population, the stratified decision-making pathways may help preserve the benefits of enhanced recovery while reducing avoidable iatrogenic harm and improving clinical feasibility. This, however, represents a conceptual framework requiring prospective validation.
SN - 1176-9092
SN - 1178-1998
ER -